BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tajiri K, Shimizu Y. New horizon for radical cure of chronic hepatitis B virus infection. World J Hepatol 2016; 8(21): 863-873 [PMID: 27478536 DOI: 10.4254/wjh.v8.i21.863]
URL: https://www.wjgnet.com/1948-5182/full/v8/i21/863.htm
Number Citing Articles
A.J. Uriel, P. Martin. Reference Module in Biomedical Sciences2019;  doi: 10.1016/B978-0-12-801238-3.02508-3
Devesh Tewari, Andrei Mocan, Emil D. Parvanov, Archana N. Sah, Seyed M. Nabavi, Lukasz Huminiecki, Zheng Feei Ma, Yeong Yeh Lee, Jarosław O. Horbańczuk, Atanas G. Atanasov. Ethnopharmacological Approaches for Therapy of Jaundice: Part IFrontiers in Pharmacology 2017; 8 doi: 10.3389/fphar.2017.00518
Lesley J. Scott, Henry L. Y. Chan. Tenofovir Alafenamide: A Review in Chronic Hepatitis BDrugs 2017; 77(9): 1017 doi: 10.1007/s40265-017-0754-9
Pamela Hummert, Teresa L. Parsons, Laura M. Ensign, Thuy Hoang, Mark A. Marzinke. Validation and implementation of liquid chromatographic-mass spectrometric (LC–MS) methods for the quantification of tenofovir prodrugsJournal of Pharmaceutical and Biomedical Analysis 2018; 152: 248 doi: 10.1016/j.jpba.2018.02.011
Young Kang, Siddhartha Rawat, Nicholas Duchemin, Michael Bouchard, Moses Noh. Human Liver Sinusoid on a Chip for Hepatitis B Virus Replication StudyMicromachines 2017; 8(1): 27 doi: 10.3390/mi8010027
Yasmin Badshah, Maria Shabbir, Sameen Zafar, Uzma Mussarat, Aamer Ikram, Sumbal Javed, Hashaam Akhtar. Impact of IL-12B Genetic Variants on Antiviral Treatment Response among Hepatitis B Patients in PakistanLivers 2023; 3(3): 494 doi: 10.3390/livers3030034
Ji Yu, Haiyong Jia, Xiaowei Guo, Samuel Desta, Shuo Zhang, Jian Zhang, Xiao Ding, Xiaohong Liang, Xinyong Liu, Peng Zhan. Design, synthesis, and evaluation of novel heteroaryldihydropyrimidine derivatives as non‐nucleoside hepatitis B virus inhibitors by exploring the solvent‐exposed regionChemical Biology & Drug Design 2020; 95(6): 567 doi: 10.1111/cbdd.13512
Erik De Clercq. Role of tenofovir alafenamide (TAF) in the treatment and prophylaxis of HIV and HBV infectionsBiochemical Pharmacology 2018; 153: 2 doi: 10.1016/j.bcp.2017.11.023
L. Salleras. Veinticinco años de vacunación sistemática frente a la hepatitis B de los preadolescentes en CataluñaVacunas 2017; 18(2): 59 doi: 10.1016/j.vacun.2017.09.001
L. Salleras. 25 years of systematic hepatitis B vaccination of pre-adolescents in CataloniaVacunas (English Edition) 2017; 18(2): 59 doi: 10.1016/j.vacune.2017.11.005
Magda Rybicka, Krzysztof Piotr Bielawski. Recent Advances in Understanding, Diagnosing, and Treating Hepatitis B Virus InfectionMicroorganisms 2020; 8(9): 1416 doi: 10.3390/microorganisms8091416